نتایج جستجو برای: aripiprazolebinary systemscyclodextrinin vitro dissolution phase
تعداد نتایج: 1007054 فیلتر نتایج به سال:
The main purpose of this work was to compare the effects four preparation methods on TFLX/HP-β-CD inclusion complex. different complex were investigated by SEM, DSC, PXRD, FT-IR and 1H NMR. All characterization information indicated that could cause interaction between TFLX HP-β-CD, but prepared solvent evaporation has more reaction sites. Phase solubility experiments demonstrated spontaneous. ...
The purpose of the present study was to investigate the effect of polyethylene glycol (PEG) molecular weights (6000, 12000 and 20000) as solid dispersion (SD) carriers on the dissolution behavior of simvastatin. SDs with various drug : carrier ratios were prepared by solvent method and evaluated for dissolution rate. Differential scanning calorimetry (DSC), X-ray diffraction (XRD), infrared spe...
Detailed study of actinide oxide behavior in alveolar macrophages (AM) in vitro is limited because of the short life span of these cells in culture. We created an in vitro dissolution system that could mimic the acidic phagolysosomal environment for the actinide and be maintained for an indefinite period so that dissolution of more insoluble materials could be measured. The dissolution system f...
The goal of this study was to increase the aqueous solubility and dissolution rate sinapic acid (SA) by formulating binary inclusion complex (BIC) SA with hydroxypropyl-?-cyclodextrin (HP?CD) using solvent evaporation (SE) technology. phase studies were conducted determine in vitro release SA. In addition, prepared characterized for solid state characterization techniques such as DSC, PXRD, SEM...
The present study is carried out for the analytical development and formulation of ramipril and hydrochlorothiazide in combination with selective excipients. The objective of drug and excipient compatibility considerations and practical studies is to delineate, as quickly as possible, real and possible interactions between potential formulation excipients and the Active Pharmaceutical Ingredien...
P granules and other RNA/protein bodies are membrane-less organelles that may assemble by intracellular phase separation, similar to the condensation of water vapor into droplets. However, the molecular driving forces and the nature of the condensed phases remain poorly understood. Here, we show that the Caenorhabditis elegans protein LAF-1, a DDX3 RNA helicase found in P granules, phase separa...
The effect of formulation parameters on the in vitro release profile of a poorly soluble drug was investigated using rimonabant as model drug. A dissolution test was developed to evaluate the release profile of rimonabant from both 20mg film-coated tablet and capsule dosage forms. The test was applied to compare dissolution profiles of different dosage forms and to evaluate the effect of formul...
Diosmin (DSN) is an outstanding phlebotonic flavonoid with a tolerable potential for the treatment of colon and hepatocellular carcinoma. Being highly insoluble, DSN bioavailability suffers from high inter-subject variation due to variable degrees of permeation. This work endeavored to develop novel DSN loaded phytosomes in order to improve drug dissolution and intestinal permeability. Three pr...
Poorly water-soluble drugs often suffer from limited or irreproducible clinical response due to their low solubility and dissolution rate. In this study, organic solvent-free solid dispersions (OSF-SDs) containing telmisartan (TEL) were prepared using polyvinylpyrrolidone K30 (PVP K30) and polyethylene glycol 6000 (PEG 6000) as hydrophilic polymers, sodium hydroxide (NaOH) as an alkalizer, and ...
Development and Validation of Discriminating and Biorelevant Dissolution Test for Lornoxicam Tablets
The establishment of biorelevant and discriminating dissolution procedure for drug products with limited water solubility is a useful technique for qualitative forecasting of the in vivo behavior of formulations. It also characterizes the drug product performance in pharmaceutical development. Lornoxicam, a BCS class-II drug is a nonsteroidal antiinflammatory drug of the oxicam class, has no of...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید